contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


raysearch-laboratories-interim-report-july-september-2024

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

RaySearch Laboratories är verksamt inom medicinteknik. Bolaget är specialiserat inom utveckling av mjukvarulösningar för sjukvårdsindustrin. Bolagets produkter används främst inom behandling av cancer och andra allvarliga sjukdomar, och vidaresäljs som dosplanerings- respektive informationssystem. Olika funktioner inkluderar maskininlärning, beräkningshastighet, automatiserad planering, virtuell simulering, adaptiv terapi och digitala arbetsflöden. Produkterna används av ett flertal kliniker.

Raysearch Laboratories

THIRD QUARTER (JULY - SEPTEMBER 2024)Order intake SEK 253.4 M (240.7)Net sales SEK 293.3 (252.9)Operating profit SEK 61.8 M (28,6)Profit after tax SEK 45.4 M (21,6)Earnings per share before/...

THIRD QUARTER (JULY - SEPTEMBER 2024)<ul><li>Order intake SEK 253.4 M (240.7)</li><li>Net sales SEK 293.3 (252.9)</li><li>Operating profit SEK 61.8 M (28,6)</li><li>Profit after tax SEK 45.4 M (21,6)</li><li>Earnings per share before/after dilution SEK 1.32 (0.63)</li><li>Cash flow from operating activities SEK 60.5 M (124.4)</li><li>Order backlog SEK 1,732.0 M (1,966.3) at the end of the period</li></ul>NINE MONTHS (JANUARY - SEPTEMBER 2024)<ul><li>Order intake SEK 782.1 M (686.5)</li><li>Net sales SEK 869.4 M (722.5)</li><li>Operating profit SEK 186.9 M (70.5)</li><li>Profit after tax SEK 143.5 M (50.0)</li><li>Earnings per share before/after dilution SEK 4.19 (1.46)</li><li>Cash flow from operating activities SEK 382.3 M (340.2)</li></ul>SIGNIFICANT EVENTS DURING THE SECOND QUARTER<ul><li>Connect Proton Therapy Center in the USA has placed an order for RayStation</li><li>Iridium Network first center in the world to use RayCare with TrueBeam&nbsp;to treat a patient</li></ul>SIGNIFICANT EVENTS AFTER THE END OF THE REPORTING PERIOD<ul><li>GenesisCare in the UK has placed an order for RayStation</li><li>RaySearch now has more than 100 RayStation customers in China</li><li>Three centers in the French Unicancer network choose RayStation</li><li>Nina Grönberg has been appointed as the new CFO and will take office in January 2025</li><li>Institut Curie selects RayStation for proton planning</li><li>The Board has decided to raise the target for the operating margin to at least 25 (20) percent by 2026</li></ul>WEBCASTCEO Johan Löf and Interim CFO Annika Blondeau Henriksson will present RaySearch's interim report for July-September 2024 in a webcast to be held in English on Friday, November 8, 2024, at 10:00 a.m. CET.Link to webcast: RaySearch Q3, 2024&nbsp;(https://events.teams.microsoft.com/event/43b79242-60a8-41ce-807f-8f70e61de732@50ba1ecf-6812-4030-81b8-a9b983f4f358)The information contained in this interim report is such that RaySearch Laboratories AB (publ) is obliged to disclose under the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication on November 8, 2024, at 7:45 a.m. CET.FOR MORE INFORMATION, PLEASE CONTACT:Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)Telephone: +46 (0) 8 510 530 00johan.lof@raysearchlabs.comAnnika Blondeau Henriksson, Interim CFO, RaySearch Laboratories AB (publ)Telephone: +46 (0) 8 510 530 00annika.henriksson@raysearchlabs.com

RaySearch Laboratories: Interim report July - September 2024

Wall Streetin arvostustasoihin verrattuna Eurooppakin näyttää nyt houkuttelevalta

Federal Reserven korkopäätös: Kiire loppui tähän

Drug development investment: Value creation through M&As and licensing agreements

EKP:n korkopäätös: Keskuspankki ilman rajoitteita

Euroalueen ostopäälliköt: Onks sen jälkeen vielä mäki?

Beställ vårt nyhetsbrev — inget användarkonto krävs!